Rosario Montoya
Overview
Explore the profile of Rosario Montoya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
604
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bailon N, Ramos E, Alvarado K, Bernaola L, Wilson J, Montoya R, et al.
Wellcome Open Res
. 2023 Sep;
8:171.
PMID: 37766850
: Some sputum smear microscopy protocols recommend placing filter paper over sputum smears during staining for (TB) We found no published evidence assessing whether this is beneficial. We aimed to...
2.
Datta S, Gilman R, Montoya R, Quevedo Cruz L, Valencia T, Huff D, et al.
Eur Respir J
. 2020 May;
56(2).
PMID: 32366485
Background: Global tuberculosis policy increasingly emphasises broad tuberculosis impacts and highlights the lack of evidence concerning tuberculosis-related quality of life (QOL). Methods: Participants were recruited in 32 Peruvian communities between...
3.
Saunders M, Wingfield T, Datta S, Montoya R, Ramos E, Baldwin M, et al.
Lancet Infect Dis
. 2019 Nov;
20(1):110-122.
PMID: 31678031
Background: The epidemiological impact and cost-effectiveness of social protection and biomedical interventions for tuberculosis-affected households might be improved by risk stratification. We therefore derived and externally validated a household-level risk...
4.
Datta S, Alvarado K, Gilman R, Valencia T, Aparicio C, Ramos E, et al.
PLoS One
. 2019 May;
14(4):e0214131.
PMID: 31039160
Background: Assessing Mycobacterium tuberculosis (TB) viability by fluorescein diacetate (FDA) microscopy can predict TB culture results, treatment response and infectiousness. However, diverse methods have been published. We aimed to optimise...
5.
Saunders M, Tovar M, Collier D, Baldwin M, Montoya R, Valencia T, et al.
Lancet Infect Dis
. 2019 Mar;
19(5):519-528.
PMID: 30910427
Background: Active case-finding among contacts of patients with tuberculosis is a global health priority, but the effects of active versus passive case-finding are poorly characterised. We assessed the contribution of...
6.
Saunders M, Wingfield T, Tovar M, Herlihy N, Rocha C, Zevallos K, et al.
Trop Med Int Health
. 2018 Jun;
23(8):850-859.
PMID: 29862612
Objectives: Mobile phone interventions have been advocated for tuberculosis care, but little is known about access of target populations to mobile phones. We studied mobile phone access among patients with...
7.
Saunders M, Wingfield T, Tovar M, Baldwin M, Datta S, Zevallos K, et al.
Lancet Infect Dis
. 2017 Aug;
17(11):1190-1199.
PMID: 28827142
Background: Contacts of tuberculosis index cases are at increased risk of developing tuberculosis. Screening, preventive therapy, and surveillance for tuberculosis are underused interventions in contacts, particularly adults. We developed a...
8.
Datta S, Sherman J, Tovar M, Bravard M, Valencia T, Montoya R, et al.
J Infect Dis
. 2017 May;
216(5):514-524.
PMID: 28510693
Background: Sputum from patients with tuberculosis contains subpopulations of metabolically active and inactive Mycobacterium tuberculosis with unknown implications for infectiousness. Methods: We assessed sputum microscopy with fluorescein diacetate (FDA, evaluating...
9.
Wingfield T, Tovar M, Huff D, Boccia D, Montoya R, Ramos E, et al.
Bull World Health Organ
. 2017 May;
95(4):270-280.
PMID: 28479622
Objective: To evaluate the impact of socioeconomic support on tuberculosis preventive therapy initiation in household contacts of tuberculosis patients and on treatment success in patients. Methods: A non-blinded, household-randomized, controlled...
10.
Wingfield T, Tovar M, Huff D, Boccia D, Saunders M, Datta S, et al.
Clin Med (Lond)
. 2016 Dec;
16(Suppl 6):s79-s91.
PMID: 27956446
Poverty drives tuberculosis (TB) rates but the approach to TB control has been disproportionately biomedical. In 2015, the World Health Organization's End TB Strategy explicitly identified the need to address...